Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. scores highest on Anchor (55) and lowest on Nitro (24). Its PosiPenta is 41.72 out of 100, around the middle of similar companies.
On the Penta Grid this week, Vanda Pharmaceuticals Inc. is Grid #477 of 837 in the Healthcare sector in United States, and Grid #2,716 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc. | 41.72 | 38 | 48 | 24 | 43 | 55 |
| Monogram Technologies Inc. | 50.30 | 2 | 45 | 94 | 38 | 72 |
| Immuneering Corporation | 44.51 | 37 | 32 | 33 | 58 | 62 |
| Lifecore Biomedical, Inc. | 33.50 | 0 | 46 | 73 | 2 | 46 |
| American Well Corporation | 54.33 | 40 | 40 | 85 | 67 | 39 |
| Lineage Cell Therapeutics, Inc. | 41.05 | 16 | 56 | 39 | 52 | 41 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.87 |
| P/B ratio | 1.11 |
EEarnings
| Trailing EPS | ₹-438.53 |
| Forward EPS | ₹18.94 |
NNitro
| Price | 381.70 |
| 52-week high | 941.47 |
| 52-week low | 378.39 |
| Fall from 52-week high | 59.5% |
TTorque
| Return on equity (ROE) | -77.81% |
| Debt-to-equity | 0.10 |
AAnchor
| Beta (price swings) | 0.69 |
| Market cap | ₹2,307 Cr |
| Insider holding | 6.78% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Vanda Pharmaceuticals Inc.'s PosiPenta score?
Vanda Pharmaceuticals Inc.'s PosiPenta is 41.72 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Vanda Pharmaceuticals Inc. stand on the Penta Grid?
On the Penta Grid this week, Vanda Pharmaceuticals Inc. is Grid #477 of 837 in the Healthcare sector in United States, and Grid #2,716 of 4,000 in United States.
Which PosiPenta pillar is strongest for Vanda Pharmaceuticals Inc.?
Anchor (stability and dividends), with a score of 55 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Vanda Pharmaceuticals Inc.?
Nitro (momentum), with a score of 24 out of 100: weaker than most similar companies.
Has Vanda Pharmaceuticals Inc.'s PosiPenta changed since last week?
Yes, it rose 3.51 points, from 38.21 to 41.72.
PositoAI is for research and education only and is not investment advice.